Giant Biogene Holding Co (HKSE:02367) Gross Profit : HK$3,224 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Gross Profit?

Giant Biogene Holding Co's gross profit for the six months ended in Dec. 2023 was HK$1,746 Mil. Giant Biogene Holding Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3,224 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Giant Biogene Holding Co's gross profit for the six months ended in Dec. 2023 was HK$1,746 Mil. Giant Biogene Holding Co's Revenue for the six months ended in Dec. 2023 was HK$2,098 Mil. Therefore, Giant Biogene Holding Co's Gross Margin % for the quarter that ended in Dec. 2023 was 83.20%.

Giant Biogene Holding Co had a gross margin of 83.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 5 years, the highest Gross Margin % of Giant Biogene Holding Co was 87.24%. The lowest was 83.28%. And the median was 84.39%.

Giant Biogene Holding Co Gross Profit Historical Data

The historical data trend for Giant Biogene Holding Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Gross Profit Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

886.54

1,193.81

1,658.34

2,228.11

3,223.52

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Profit	Get a 7-Day Free Trial			-	982.60	1,292.02	1,477.69	1,745.83

Competitive Comparison of Giant Biogene Holding Co's Gross Profit

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's Gross Profit Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Gross Profit falls into.

Giant Biogene Holding Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Giant Biogene Holding Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	3854.633	-	631.117
	=	3,224

Giant Biogene Holding Co's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	2098.355	-	352.53
	=	1,746

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3,224 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Giant Biogene Holding Co's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	1,746	/	2098.355
	=	83.20 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Giant Biogene Holding Co (HKSE:02367) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Giant Biogene Holding Co had a gross margin of 83.20% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Giant Biogene Holding Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines